Microfluidic Systems for Antimicrobial Susceptibility Testing.

Area of Science:

• Biomedical Engineering
• Microfluidics
• Infectious Diseases

Background:

• Antimicrobial resistance (AMR) is a major global health threat.
• Standard antimicrobial susceptibility testing (AST) methods are slow and labor-intensive.
• This leads to delayed or inappropriate antibiotic treatments, fueling AMR.

Purpose of the Study:

• To explore microfluidic systems as a solution for rapid AST.
• To reduce the time needed for antimicrobial susceptibility detection.
• To combat the spread of antimicrobial resistance by enabling faster, targeted therapies.

Main Methods:

• Overview of conventional AST methods.
• Presentation of various microfluidic approaches for AST.
• Focus on microfluidic methods for phenotypic antimicrobial susceptibility testing.
• Discussion of using human samples with minimal pretreatment.

Main Results:

• Microfluidic systems offer reduced detection times using small sample volumes.
• Single-cell detection is achievable with microfluidic platforms.
• Potential for point-of-care applications in AST.

Conclusions:

• Microfluidics shows significant promise for rapid phenotypic AST.
• Faster AST can minimize empirical broad-spectrum antibiotic use.
• Developing rapid AST is crucial for combating antimicrobial resistance.